EZH2 and leukemia: Secondary leukemias were then generated using transplantation of primary splenic tissue into WT lethally irradiated recipients, and Ezh2 deletion was achieved in situ in the test mice, following adequate engraftment, by the administration of pIpC (or PBS injections in the control arm) in recipient mice.